Blackrock Neurotech

Salt Lake City, United States Founded: 2008 • Age: 18 yrs Acquired By Tether
Medical devices for neurological therapies are developed.
Annual revenue - Latest available
Total funding $22.4M 16 rounds
Employees - Tracked headcount
Investors 7 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Blackrock Neurotech

Blackrock Neurotech is a company based in Salt Lake City (United States) founded in 2008 by Florian Solzbacher and Marcus Gerhardt was acquired by Tether in April 2024. Blackrock Neurotech has raised $22.37 million across 16 funding rounds from investors including HHS, European Union and Tether. Blackrock Neurotech has completed 1 acquisition, including HAHA69. Blackrock Neurotech operates in a competitive market with competitors including Cepheid, Beckman Coulter, Bruker, Esco Lifesciences and Agilent, among others.

  • Headquarter Salt Lake City, United States
  • Founders Florian Solzbacher, Marcus Gerhardt
  • Sectors
    Healthcare
    Technology
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Blackrock Microsystems Llc
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Technology → Artificial Intelligence & Machine Learning Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $22.37 M (USD)

    in 16 rounds

  • Latest Funding Round
    $12.37 M (USD), Series B

    Apr 29, 2024

  • Investors
    HHS

    & 6 more

  • Employee Count
    Not available
  • Investments & Acquisitions
  • Acquired by
    Tether

    (Apr 29, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Blackrock Neurotech

Headcount 50-200
Employee Profiles 49
Board Members and Advisors 3
Employee Profiles
People
Balaji Srikanthan
Senior Research And Development Engineer
People
Rishabh Vats
Senior Quality Engineer
People
Marcus Gerhardt
Co-Founder & CEO
People
Julia Brown
Head Of Data Strategy & AI

Unlock access to complete

Board Members and Advisors
people
Christian Angermayer
Co-Chairman
people
Tim Sievers
Co-Chairman
people
Pierre-Emmanuel Gaillardon
Advisor

Unlock access to complete

Funding Insights of Blackrock Neurotech

Blackrock Neurotech has successfully raised a total of $22.37M across 16 strategic funding rounds. The most recent funding activity was a Series B round of $12.37 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Blackrock Neurotech

Blackrock Neurotech has secured backing from 7 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include HHS, European Union and Tether.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Early-stage investments are provided in mental health and brain health sectors.
Locked Locked Locked
Public health and human services are overseen by HHS.
Locked Locked Locked
Administers health care and support for military personnel and operations.
Locked Locked Locked
Premium access

Investor details for Blackrock Neurotech

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Blackrock Neurotech

Blackrock Neurotech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include HAHA69.

Investments
Premium access

Investment portfolio details for Blackrock Neurotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
HAHA69 is recognized for providing online slot gaming services.
Locked Locked 2016 Locked
Premium access

Complete acquisition details for Blackrock Neurotech

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Blackrock Neurotech

Premium access

Detailed financials for Blackrock Neurotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Blackrock Neurotech Comparisons

Blackrock Neurotech Primary company
Description
Medical devices for neurological therapies are developed.
Location
Salt Lake City, United States
Founded Year
2008
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Blackrock Neurotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Blackrock Neurotech

Blackrock Neurotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Beckman Coulter, Bruker, Esco Lifesciences and Agilent, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of molecular diagnostic testing solutions
Locked Locked Locked
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
Locked Locked Locked
Diversified research instrument systems are manufactured and supplied.
Locked Locked Locked
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
Locked Locked Locked
Diversified instruments are developed for scientific and laboratory management.
Premium access

Detailed competitors of Blackrock Neurotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Blackrock Neurotech

Premium access

Complete news archive for Blackrock Neurotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Blackrock Neurotech

Blackrock Neurotech was founded in 2008 and raised its 1st funding round 1 year after it was founded.

Blackrock Neurotech is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.

Marcus Gerhardt is the current CEO of Blackrock Neurotech. They have also founded this company.

Blackrock Neurotech is a funded company, having raised a total of $22.37M across 16 funding rounds to date.

Blackrock Neurotech developer of medical devices for neurological therapies through life sciences, neurology, developing medical devices, therapeutic devices, neurorehabilitation, and clinic based. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Blackrock Neurotech's top competitors include Cepheid, Agilent and Esco Lifesciences.

Blackrock Neurotech has made 1 acquisition, including HAHA69.

Blackrock Neurotech has 7 investors. Key investors include HHS, European Union, Tether, re.Mind Capital, and Peter Thiel.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available